Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001387131-18-005357

Director sold 182,800 shares at an average $5.91 ($1,080,348)

  • Director acquired 182,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bernick Brian · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-04 Exercise or conversion : show line 1 in the form +91,400 $0.10 $9,305 6,648,771 I
2018-10-04 Sale : show line 2 in the form −91,400 $5.89 $538,346 6,557,371 I
2018-10-05 Exercise or conversion : show line 3 in the form +91,400 $0.10 $9,305 6,648,771 I
2018-10-05 Sale : show line 4 in the form −91,400 $5.93 $542,002 6,557,371 I
Open-market sales · 182,800 sh · avg $5.91 · $1,080,348

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-10-04 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) −91,400 1,005,910 I
2018-10-05 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −91,400 914,510 I
Loading xslF345X03/ownership.xml…